Insulet (PODD) Current Taxes (2011 - 2012)
Insulet (PODD) posted Current Taxes of $4.0 million for Q4 2012, up 1505.26% on a QoQ basis from $247000.0 in Q4 2011, and up 1505.26% year-over-year from $247000.0 in Q1 2012.
Insulet (PODD) Current Taxes (2011 - 2012) Analysis & Trends
Insulet's Current Taxes history runs 2 years deep, the most recent figure standing at $4.0 million for Q4 2012.
- Quarterly Current Taxes rose 1505.26% year-over-year to $4.0 million in Q4 2012, while the trailing twelve-month figure through Dec 2012 was $4.0 million (up 1505.26% YoY) and the FY2012 annual result came in at $4.0 million, up 1505.26% from the prior year.
- Current Taxes was $4.0 million for Q4 2012 at Insulet, up from $247000.0 in the prior quarter.
- Across five years, Current Taxes topped out at $4.0 million in Q4 2012 and bottomed at $247000.0 in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 598.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 476.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 914.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 194.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 231.81 Mn |
| 10 | Insulet | 11.52 Bn | 11.04 Bn | 529.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 3.97 Mn |
| Dec 31, 2011 | 247,000.00 |